NCT06469658 - Personalized Management of Type 2 Diabetes Using AI-Guided (GenAIS TM) Dietary Supplementation | Biotech Hunter

Enrollment

160

Participants

Timeline

Start Date

February 2, 2024

Primary Completion Date

May 15, 2024

Study Completion Date

June 3, 2024

Conditions

Diabetes

Interventions

OTHER

The standard practice dietary supplements intervention

Participants receive supplements prescriptions from a physician based on current standard practices, which include biochemical markers, genetic data, and metabolic profiles.

OTHER

The AI-guided practice dietary supplements group

Participants receive DS prescriptions determined by GenAIS, an AI system which considers genetic data, metabolic profiles, biochemical markers, and patient history.

Trial Locations (1)

630090

Center of New Medical Technologies, Novosibirsk